The most common and toxic form of aflatoxin, aflatoxin B 1 (AFB 1 ), is produced by molds growing on crops. Use of moldy corn can result in high concentrations of AFB 1 in swine diets, which could potentially lead to an increased incidence of aflatoxicosis, a disease associated with decreased health and performance through reduced feed intake, reduced BW gain, and impaired liver function. The objective of this study was to determine the effects of AFB 1 on the hepatic gene expression of growing barrows. Ninety Duroc × Yorkshire crossbred barrows (age = 35 ± 5 d; initial BW = 14.2 ± 3.0 kg) were allocated to 9 pens with 10 pigs per pen, and randomly assigned in a 3 × 3 factorial arrangements of treatments to receive diets containing 0 µg/kg of AFB 1 , 250 µg/kg of AFB 1 , or 500 µg/kg of AFB 1 for 7, 28, or 70 d. Because performance was most affected in animals administered AFB 1 for an extended period, liver samples from d 70 animals were used for RNA-sequencing analysis. Of 82,744 sequences probed, 179 had transcripts that were highly correlated (r ≥ |0.8|; P < 0.0001) with treatment. Of the 179 significant transcripts, 46 sequences were negatively and 133 sequences positively related to treatment. Forty-three unique functional groups were identified. Genes within the apoptosis regulation functional group were selected for 1) confirmation of d 70 gene expression differences using real-time reverse-transcription (RT)-PCR (n = 4 genes), and 2) investigation of d 7 expression to identify early responses to AFB 1 (n = 15 genes) using real-time RT-PCR. Expression of the 4 apoptosis genes selected for confirmation, cyclin-dependent kinase inhibitor 1A, zinc finger matrin type 3, kininogen 1, and pim-1 oncogene, was confirmed with real-time RT-PCR. Of the 15 genes tested in d 7 liver samples, 4 were differentially expressed: cyclin-dependent kinase inhibitor 1A; zinc finger matrin type 3; tyrosine 3-monooxygenase/ tryptophan 5-monooxygenase activation protein, zeta polypeptide; and apoptosis enhancing nuclease. Results from this study demonstrate that administration of an AFB 1 -contaminated diet to growing barrows alters hepatic gene expression, and in particular apoptosis genes.
INTRODUCTION
Mycotoxins are secondary metabolites produced by molds on crops grown in stressful or poor conditions (Dharmarha, 2009) . Aflatoxins are among the most potent mycotoxins, of which aflatoxin B 1 (AFB 1 ) is the most toxic (Devegowda and Murthy, 2005) . Feeds contaminated with AFB 1 can cause aflatoxicosis, which is manifest through liver damage and subsequently poor health and performance. Susceptibility varies with species, age, AFB 1 concentration, and duration of exposure (CAST, 2003) . Regulatory limits for total AFB 1 in swine feed are <20 µg/kg of AFB 1 for young pigs, <100 µg/ kg of AFB 1 for breeding pigs, and <200 µg/kg of AFB 1 for finishing pigs (Dharmarha, 2009; .
Distillers dried grains with solubles (DDGS) are a coproduct of ethanol production and commonly used as an energy source in ruminant diets. However, because aflatoxins produced on corn are not destroyed during ethanol production, but instead are concentrated 3-to 4-fold (FDA, 2006; Wilkinson and Abbas, 2008) , the use of DDGS in swine diets can be problematic. No treatment for aflatoxicosis currently exists, and although AFB 1 content in DDGS is typically low , mycotoxin sampling and testing procedures can be difficult and inconsistent, limiting the reliability of detection.
Identification of genes and pathways altered by dietary aflatoxins may lead to enhanced diagnostic, treatment, and prevention strategies for aflatoxicosis. Additionally, gene expression profiles may provide a means of identifying animals more or less susceptible to aflatoxicosis, or differentiate the subtype of aflatoxin causing toxicity, similar to the use of gene expression profiling to classify scrapie strains in affected mice (Booth et al., 2004) . The objective of this study was to identify hepatic genes differentially expressed among growing barrows fed diets containing no AFB 1 , a low level of AFB 1 , or a high level of AFB 1 for 7, 28, or 70 d.
MATERIALS AND METHODS
All animal procedures used were approved by the University of Wyoming Institutional Animal Care and Use Committee.
Animal Procedures
The experimental design for this study was described previously by Rustemeyer et al. (2010) . Briefly, 90 Duroc × Yorkshire crossbred barrows (age = 35 ± 5 d; initial BW = 14.2 ± 3.0 kg) were randomly assigned in a 3 × 3 factorial arrangement of treatments to receive 0 µg/kg of AFB 1 (CON), 250 µg/kg of AFB 1 (LO), or 500 µg/kg of AFB 1 (HI) for 7, 28, or 70 d. Barrows were allowed a 6-d adaptation period before starting their respective dietary treatment (d −6 to −1). Barrows were allowed ad libitum access to feed and water throughout the study and were fed a standard starter diet from d 0 to 20, followed by a standard grower diet from d 21 to 70. Ground corn containing AFB 1 culture material was added to the LO and HI starter and grower diets to reach dietary concentrations of 250 and 500 µg/kg of AFB 1 , respectively. Barrows were monitored daily for signs of aflatoxicosis, including decreased feed intake, icterus, rough coat, and lethargy (Coppock et al., 1989; Harvey et al., 1990) . Pen feed intake was measured daily, and pigs were weighed and blood samples were collected weekly. Blood samples (10 mL) were collected via jugular venipuncture into 16-× 100-mm blood collection tubes (Tyco Healthcare Group LP, Mansfield, MA). Samples were allowed to clot for ≥20 min at room temperature and then centrifuged for 20 min at 1,200 × g at 4°C. Serum was collected and stored at −20°C until serum analyses (Rustemeyer et al., 2010) . Pigs were killed on the last day of their respective treatment period for tissue collection; liver samples were collected, snap-frozen on dry-ice after collection, and stored at −80°C. Total RNA was isolated from those hepatic tissues, and RNA sequencing (RNA-Seq) was conducted at the DNA Core (University of Missouri, Columbia) on RNA isolated from the d 70 samples.
RNA Isolation
Liver tissue samples (0.05 to 0.1 g, as-is basis) from d 70 and 7 barrows were used for RNA extractions with Trizol according to standard manufacturer's instructions (Sigma-Aldrich, St. Louis, MO). The RNA was purified using the RNeasy clean-up kit protocol (Qiagen, Valencia, CA), which included on-column DNase digest. All purified RNA was measured for quality and quantity using a NanoDrop spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE). Samples were aliquotted into 2-µg fractions for real-time reversetranscription (RT)-PCR analysis, and 10-µg fractions for RNA-Seq analysis (d 70 samples only).
RNA-Seq
Quality analysis was performed on each d 70 sample before library preparation using the Experion RNA Analysis Kit (Bio-Rad, Hercules, CA) at the University of Missouri DNA Core. A total of 9 CON, 6 LO, and 9 HI samples were selected for RNA-Seq based on quality.
Library Preparation for RNA-Seq
Sera-mag oligo (dT) beads (Illumina Inc., San Diego, CA) were used to isolate and purify poly-A containing mRNA from total RNA according to the library preparation protocol. The mRNA was fragmented with the 5X Fragmentation Buffer (Illumina) for exactly 5 min to target the 200-bp region. First-strand cDNA, then second-strand cDNA was synthesized using the SuperScript II Reverse Transcriptase kit (Invitrogen, Carlsbad, CA) according to manufacturer's instructions. Samples were purified according to QIAquick PCR Purification Kit instructions (Qiagen) and eluted in 50 µL of elution buffer (Buffer EB, Qiagen). End repair was performed and samples were purified again according to instructions in QIAquick PCR Purification Kit (Qiagen) and eluted in 32 µL of elution buffer. Then A bases were added to the 3′ end of cDNA fragments and the cDNA was purified per MinElute PCR Purification Kit instructions (Qiagen) and eluted in 23 µL of elution buffer. A unique 4-bp sequence (i.e., barcode) was added to each sample to allow for pooling of samples in the flowcells and yet collection of individual sequence data. Barcoded adapters were ligated to the cDNA fragments, and the cDNA was again purified per MinElute PCR Purification Kit instructions (Qiagen) and eluted in 13 µL of elution buffer. Further purification and selection of the cDNA templates was completed through electrophoresis of the samples on a 2% agarose gel at 120 V for 45 to 50 min. The 200-bp region of the sample was excised from the gel. Samples were purified using the QIAquick Gel Extraction Kit (Qiagen) and eluted in 30 µL of elution buffer. The 30-µL purified cDNA templates were combined with 10 µL of 5× Phusion Buffer, 1 µL of PCR Primer 1, 1 µL of PCR Primer 2, 0.5 µL of 25 mM Deoxynucleotide Triphosphate Mix, 0.5 µL of Phusion DNA Polymerase, and 7 µL of water, and enriched using PCR consisting of 30 s at 98°C; 15 cycles of 10 s at 98°C, 30 s at 65°C, and 30 s at 72°C; and a final extension of 5 min at 72°C. Samples were again purified using the QIAquick PCR Purification Kit (Qiagen) and eluted in 20 µL of elution buffer. Gel electrophoresis of cDNA samples was conducted on a 2% agarose gel at 120 V for 45 to 50 min to validate the libraries. The 200-bp region of the sample was again excised from the gel. The extracted cDNA samples were again purified using the QIAquick Gel Extraction Kit (Qiagen) and eluted in 20 µL of elution buffer. The DNA samples were diluted with a 99.9% elution buffer and 0.1% Tween20 mixture to achieve working stocks of 10 nM per sample.
RNA-Seq Analysis
The RNA-Seq was conducted at the University of Missouri DNA Core using the Illumina Genome Analyzer (Illumina). Samples from 3 animals (10 nM working stocks described above) each with a unique barcode, but like treatment (CON, LO, or HI), were combined, diluted to 4 to 12 pM single-stranded sequences, and added to each lane, for a total of 24 samples distributed among treatments as described previously (9 CON, 6 LO, and 9 HI) across the 8 lanes. In the cluster station (Illumina), the samples were applied to the flowcell where clusters of each oligo were replicated through bridge amplification, with the amount of initial RNA corresponding with the number of clusters for each transcript. After amplification, the flowcell was placed in the sequencing machine, where fluorescently labeled bases (unique to each A, C, G, and T) were attached to the complementary bases of the RNA sequences. Laser excitation was used to activate the fluorescently labeled bases. The Illumina Genome Analyzer (Illumina) then recorded the first 42 bases of each labeled sequence, with the first 4 bases being the barcoded adapters to identify each sample. The sequence information was recorded and compiled for each sample, and stored at the University of Missouri. For each unique transcript of a sample, the number of copies was quantified. This transcript copy number was relative to transcript abundance, and hence mRNA abundance.
RNA-Seq Statistical Analysis
Transcripts with ≥10 copies and fold change >2 between at least 2 of the treatments were used for further analysis. Treatments were assigned relative levels, with CON = 0, LO = 1, and HI = 2. Correlation coefficients between transcript copy number and treatment were estimated for each unique transcript using Microsoft Excel (Microsoft Corp., Redmond, WA). For those transcripts with a significant correlation coefficient (r ≥ |0.80|; P < 0.0001), linear regression of transcript copy number on treatment was also performed. Genes associated with transcripts with significant correlation coefficients were identified by BLASTing the transcript sequence against the Human Genome (http://www. ornl.gov/sci/techresources/Human_Genome/home.shtml; Supplemental Table 1 , available at http://jas.fass. org/content/vol89/issue4/).
Gene Annotation
Genes identified as differently expressed by RNA-Seq were clustered using the greatest stringency option according to functional groups by using the Database for Annotation, Visualization, and Integrated Discovery (or DAVID; Dennis et al., 2003) using the Expression Analysis Systemic Explorer (EASE) program. A modified Fisher exact test was used within EASE to identify overrepresented functional groups. Genes within functional group(s) of interest were tested for treatment effects using the GLM procedure (SAS Inst. Inc., Cary, NC). Least squares means were estimated and tested for pair-wise treatment differences using the Tukey adjustment, assuming an α level of 0.05.
Real-Time RT-PCR
Fifteen genes were clustered within the regulation of apoptosis function by DAVID. Of those 15 genes, 2 upregulated (i.e., increased expression in AFB 1 -treated barrows compared with CON barrows) and 2 downregulated (i.e., decreased expression in AFB 1 -treated barrows compared with CON barrows) genes were chosen for confirmation with real-time RT-PCR. Griffith et al. (2010) showed a 93% correlation between quantitative PCR and RNA-Seq platforms; therefore, confirmation was performed on only 4 genes in this study. Real-time RT-PCR was also used to determine expression of all 15 of those genes in randomly selected d 7 liver samples, with 8 samples per treatment group (CON, LO, and HI). For real-time RT-PCR, 2 µg of purified RNA (described previously) were lyophilized, then converted to cDNA using the iScript cDNA Synthesis Kit (BioRad). Primers (Supplemental Table 2 ; http://jas.fass. org/content/vol89/issue4/) were designed directly from the sequences generated by RNA-Seq to have a melting temperature of 60°C and to yield 150-bp amplicons using Primer3 Software v. 0.4.0 (Rozen and Skaletsky, 2000) . All primers (apoptosis genes and the housekeeping gene) were generated from swine sequences and were confirmed by blasting the forward and reverse primers in the National Center for Biotechnology Information database (http://blast.ncbi.nlm.nih.gov/). The primers were synthesized by Invitrogen and were diluted to a 5 µM working stock. A master mix (14.5 µL) consisting of 12.5 µL of SYBR green supermix (Bio-Rad Laboratories), 1 µL each of forward and reverse primers, and 0.5 µL of H 2 O was added to 10 µL of diluted cDNA in a 96-well plate in duplicate. For the PCR reaction, the IQ5 (Bio-Rad) was programmed to run 1 cycle of 95°C for 3 min, and 40 cycles of 95°C for 10 s and 60°C for 30 s. Melting curve analysis was performed using 1 cycle of 95°C for 1 min, and then 1 cycle of 55°C for 1 min followed by a 0.5°C increase in temperature with each cycle for 81 cycles to ensure quality of amplification. For each gene, the number of threshold cycles was obtained for each sample in duplicate. Relative gene expressions were calculated using the 2 −ΔΔCT method (Livak and Schmittgen, 2001 ) and were expressed relative to glyceraldehyde 3-phosphate dehydrogenase as the housekeeping gene. Relative expression values were tested for treatment effects using the GLM procedure of SAS; least squares means were estimated and tested for pair-wise treatment differences using the Tukey adjustment, assuming an α level of 0.05.
RESULTS

Animal Performance
As previously reported by Rustemeyer et al. (2010) , average feed intake was less (P < 0.05) in HI barrows than in CON barrows from wk 5 to 10, and was less (P < 0.05) in LO barrows than in CON barrows in wk 5 and again from wk 8 to 10. Also, ADFI was less (P = 0.022) in HI barrows than LO barrows in wk 10. Decreased ADG (P < 0.05) was observed in HI barrows than in CON barrows in wk 8 and 10; no differences (P = 0.665) in ADG were noted between CON and LO barrows. Performance differences observed in this study were similar to those reported by Lindemann et al. (1993) in barrows fed 840 µg/kg of AFB 1 .
Hepatic Gene Expression: d 70
All d 70 RNA samples used for RNA-Seq exceeded minimum quality requirements based on Experion results, with an RNA Quality Indicator >8.0 on a scale of 1.0 (fully degraded) to 10.0 (intact). In total, 82,737 reads were generated and assembled using all external sequence data available at the time of the assembly. Of those sequences, 179 (Supplemental Table 1 ; http://jas. fass.org/content/vol89/issue4/) had transcript numbers that were highly correlated (r ≥ |0.8|; P < 0.0001) with treatment, and were considered differentially expressed. There were 46 sequences with a negative relationship between transcript copy number and treatment, and 133 sequences with a positive relationship. Of these 179 genes, 150 were recognized by DAVID, and subsequently clustered into 43 distinct functional groups (Table  1 ). The functional groups that contained ≥5 genes included catabolic processes, vesicle membrane, apoptosis, positive apoptosis regulation, negative apoptosis regulation, nucleotide binding, ATP binding, ion binding, zinc finger, protein kinase activity, actin binding, guanosine triphosphate binding, metabolism regulation, and reproduction. The functional groups of apoptosis regulation were selected for further genetic investigation because of the role of apoptosis in aflatoxicosis, as demonstrated by altered apoptotic gene activity (Van Vleet et al., 2006) and the presence of apoptotic cells in response to aflatoxins (Özen et al., 2009 ). The RNASeq results for the apoptosis-regulating genes, cyclindependent kinase inhibitor 1A (CDKN1A), kininogen 1 (KNG1), zinc finger matrin type 3 (ZMAT3), pim-1 oncogene (PIM1), signal transducer and activator of transcription 1, 91 kDa (STAT1), protein phosphatase 2 (catalytic subunit, β isoform; PP2CB), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ), B-cell lymphoma-2 (BCL2)/adenovirus E1B 19 kDa interacting protein 2 (BNIP2), fem-1 homolog b (FEM1B), cullin 2 (CUL2), IGF-2 (somatomedin A; insulin-IGF2 read-through transcript), NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30 kDa (NADH-coenzyme Q reductase; NDUFS3), collagen (type II, α 1; CO-L2A1), apoptosis enhancing nuclease (AEN), and neural precursor cell-expressed developmentally downregulated 8 (NEDD8) activating enzyme E1 subunit 1 (NAE1), are reported in Table 2 .
Greater expression of AEN (P < 0.001), STAT1 (P ≤ 0.001), PP2CB (P ≤ 0.003), CUL2 (P ≤ 0.001), NAE1 (P < 0.001), COL2A1 (P ≤ 0.003), NDUFS3 (P ≤ 0.008), and YWHAZ (P ≤ 0.004) was detected in LO and HI treatment groups compared with the CON group using RNA-Seq; no expression differences (P ≥ 0.085) in any of these genes were observed between LO and HI treatments. Expression of CDKN1A, BNIP2, ZMAT3, and FEMB1B was greater (P ≤ 0.039) in the LO and HI barrows than the CON barrows, and was additionally greater in HI barrows than LO barrows. Finally, expression of IGF2, PIM1, and KNG1 was less in LO and HI barrows (P < 0.001) compared with CON barrows, but no expression differences (P = 0.422) between LO and HI barrows were detected.
From the RNA-Seq data, 2 upregulated apoptosis genes, CDKN1A and ZMAT3, and 2 downregulated apoptosis genes, KNG1 and PIM1, were selected for confirmation using real-time RT-PCR (Table 3) . The RNA-Seq of d 70 samples showed CDKN1A and ZMAT3 expression as greater (P < 0.001) in LO and HI than CON barrows, and also greater (P ≤ 0.023) in HI than LO barrows. Real-time RT-PCR results were mostly in agreement with these results in the d 70 tissues; CDKN1A and ZMAT3 expression was greater in the HI (P < 0.001) and LO (P ≤ 0.009) barrows compared with the CON barrows, but not different (P ≥ 0.236) between HI and LO barrows (Tables 3 and 4 
Hepatic Gene Expression: d 7
All 15 apoptosis genes were tested for expression differences in d 7 liver samples using real-time RT-PCR (Table 5 ). There was an increase (P < 0.001) in expression of CDKN1A in LO and HI barrows compared with CON, but no expression difference (P = 0.057) in HI vs. LO barrows. Greater (P < 0.001) expression of ZMAT3 was observed in LO and HI barrows than in CON barrows; expression of ZMAT3 was additionally greater (P = 0.006) in HI vs. LO barrows. A decrease (P = 0.038) in expression of YWHAZ was observed in HI barrows compared with CON barrows, but no expression differences (P > 0.282) were observed between CON and LO barrows or between HI and LO barrows. Finally, AEN expression was greater (P < 0.001) in LO and HI barrows compared with CON, and also greater (P = 0.026) in HI barrows than LO. No differences in expression of KNG1 (P ≥ 0.203), PIM1 (P ≥ 0.226), STAT1 (P ≥ 0.439), PP2CB (P ≥ 0.744), BNIP2 (P ≥ 0.130), FEM1B (P ≥ 0.364), CUL2 (P ≥ 0.133), IGF2 (P ≥ 0.091), NDUFS3 (P ≥ 0.167), COL2A1 (P ≥ 0.284), or NAE1 (P ≥ 0.195) genes were observed in d 7 liver samples.
DISCUSSION
Apoptosis is a complex process that is necessary for regulating cell survival through removal of diseased or damaged cells. Because of the liver damage, especially DNA damage, caused by AFB 1 in swine, changes in activity of genes involved in the apoptosis process would be anticipated.
CDKN1A
Upon DNA damage, CDKN1A regulates cell cycle arrest in the p53 checkpoint pathway (Bendjennat et al., 2003) . The p53 tumor suppressor is regulated by many apoptosis genes. This transcription factor triggers cell cycle arrest, senescence, and apoptosis; too much can lead to cell death and too little can lead to tumor development (Vilborg et al., 2009 ). Cyclin-dependent kinase inhibitor 1A binds and inhibits cyclin-dependent kinase activity, preventing phosphorylation of substrates and blocking cell cycle progression. Tumor suppressor p53 can activate CDKN1A, and CDKN1A can be a negative regulator of p53 stability (Broude et al., 2007) . Overexpression of CDKN1A causes cell cycle arrest. Damage of DNA and oxidative stress induce CDKN1A expression, and loss of CDKN1A may contribute to tumor suppression through sensitized apoptotic response (Wang et al., 1997) . Additionally, phosphorylation of STAT1 leads to enhanced gene expression of CDKN1A (Hikasa et al., 2003) . An increase in expression of CDKN1A in LO and HI compared with CON barrows was observed in both d 7 and 70 samples, suggesting that this gene may be an early and constant indicator of apoptosis activity due to AFB 1 administration.
ZMAT3
Zinc finger matrin type 3 is regulated by p53 and positively regulates p53 mRNA by binding and stabilizing the mRNA to prevent its deadenylation. This act forms a positive feedback loop and increases p53 protein levels, allowing enhanced p53 response to DNA damage (Vilborg et al., 2009 (Vilborg et al., , 2010 . The increase in ZMAT3 expression in LO and HI compared with CON barrows at both d 7 and 70 may indicate that, similar Differentially expressed defined as genes with high correlations (r > |0.80|; P < 0.0001) between transcript copy number and treatment. GTP = guanosine triphosphate. Rustemeyer et al. to CDKN1A, changes in ZMAT3 expression may be an early sign of apoptotic response to AFB 1 .
KNG1
Kininogen 1 (high-molecular-weight kininogen) releases nonapeptide bradykinin, released from the interaction with plasma kallikrein. This release causes the generation of 2-chain high-molecular-weight kininogen (HKa), which can induce apoptosis of proliferating endothelial cells and inhibit angiogenesis (Merkulov et al., 2008) . Expression of KNG1 was less in HI and LO barrows compared with CON barrows at d 70 only, suggesting that KNG1 apoptotic activity is induced after a more chronic AFB 1 exposure.
PIM1
Pim-1 oncogene is a serine/threonine kinase that is involved in cell survival, proliferation, differentiation, apoptosis, and tumorigenesis (Hu et al., 2009) . Multiple cytokines activate PIM1 through the JAK/STAT pleiotropic signaling pathway, and PIM1 can also negatively regulate the JAK/STAT pathway. Pim-1 oncogene helps regulate cell apoptosis and anti-apoptotic activity by phosphorylating Bcl-xL/BCL2-associated death promoter (BAD), which is a pro-apoptotic member of the BCL2 family (Hu et al., 2009 ). Zhang et al. (2007) reported that PIM1 phosphorylates and stabilizes CD-KN1A, promoting cell proliferation and contributing to tumorigenesis. In this way, PIM1 is important to antiapoptosis signaling, which may lead to increased tumor growth. In agreement with this, PIM1 expression was decreased and CDKN1A expression increased in LO and HI barrows on d 70, indicating increased apoptosis and decreased cell survival in barrows administered AFB 1 .
STAT1
Signal transducer and activator of transcription 1 induces apoptosis and is considered a tumor suppressor (Regis et al., 2008) . Apoptosis can be regulated Within a row, means without a common superscript letter differ (P < 0.05). 1 CON = 0 µg/kg of aflatoxin B 1 ; LO = 250 µg/kg of aflatoxin B 1 ; HI = 500 µg/kg of aflatoxin B 1 . 2 Least squares means ± SE, units in copy number. 3 n = 9 for each of the CON and HI treatments; n = 6 for LO treatment. 4 Cyclin-dependent kinase inhibitor 1A (CDKN1A), B-cell lymphoma-2/adenovirus E1B 19 kDa interacting protein 2 (BNIP2), zinc finger matrin type 3 (ZMAT3), apoptosis enhancing nuclease (AEN), signal transducer and activator of transcription 1, 91 kDa (STAT1), protein phosphatase 2 (catalytic subunit, β isoform; PP2CB), cullin 2 (CUL2), neural precursor cell-expressed developmentally downregulated 8 activating enzyme E1 subunit 1 (NAE1), collagen (type II, α 1; COL2A1), NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30 kDa (NADH-coenzyme Q reductase; NDUFS3), pim-1 oncogene (PIM1), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ), kininogen 1 (KNG1), fem-1 homolog b (FEM1B). Least squares means ± SE, units in relative expression to glyceraldehyde 3-phosphate dehydrogenase (housekeeping gene). 3 n = 9 for each of the CON and HI treatments; n = 6 for LO treatment.
by STAT1 through negative regulation of Mdm2, an anti-apoptotic gene, and a p53 interaction. Along with apoptosis, STAT1 negatively regulates the cell cycle through CDKN1A upregulation, and negatively regulates cell survival genes Bcl-xl and BCL2, both antiapoptotic genes (Regis et al., 2008) . Greater expression of STAT1 was found in LO and HI d 70 samples, but no differences were found in the d 7 samples, indicating STAT1 may only regulate apoptosis after more chronic exposure to AFB 1 .
PP2CB
Protein phosphatase 2 (catalytic subunit, β isoform) is activated by unsaturated fatty acids and also requires BAD to influence apoptosis. Phosphorylation of BAD is anti-apoptotic, but dephosphorylation is pro-apoptotic. The dephosphorylation of BAD by PP2CB leads to apoptosis (Klumpp et al., 2006) . Reduced expression of PP2CB was also reported in prostate cancer (Hornstein et al., 2008) . Greater PP2CB was found in d 70 LO and Cyclin-dependent kinase inhibitor 1A (CDKN1A), zinc finger matrin type 3 (ZMAT3), kininogen 1 (KNG1), pim-1 oncogene (PIM1).
2 n = 9 for CON (0 µg/kg of aflatoxin B 1 ) and HI (500 µg/kg of aflatoxin B 1 ) treatments; n = 6 for LO (250 µg/kg of aflatoxin B 1 ) treatment.
3 n = 9 for each of the CON and HI treatments; n = 6 for LO treatment.
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Fold change values expressed as a ratio between LO and CON groups, where FC >1.00 indicates an increase in gene expression and FC <−1.00 indicates a decrease in gene expression.
5
Fold change values expressed as a ratio between HI and CON groups, where FC >1.00 indicates an increase in gene expression and FC <−1.00 indicates a decrease in gene expression. 6 Fold change values expressed as a ratio between HI and LO groups, where FC >1.00 indicates an increase in gene expression and FC <−1.00 indicates a decrease in gene expression. Within a row, means without a common superscript letter differ (P < 0.05). Least squares means ± SE, units in relative expression to glyceraldehyde 3-phosphate dehydrogenase (housekeeping gene). Cyclin-dependent kinase inhibitor 1A (CDKN1A), B-cell lymphoma-2/adenovirus E1B 19 kDa interacting protein 2 (BNIP2), zinc finger matrin type 3 (ZMAT3), apoptosis enhancing nuclease (AEN), signal transducer and activator of transcription 1, 91 kDa (STAT1), protein phosphatase 2 (catalytic subunit, β isoform; PP2CB), cullin 2 (CUL2), neural precursor cell-expressed developmentally downregulated 8 activating enzyme E1 subunit 1 (NAE1), collagen (type II, α 1; COL2A1), NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30 kDa (NADH-coenzyme Q reductase; NDUFS3), pim-1 oncogene (PIM1), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ), kininogen 1 (KNG1), fem-1 homolog b (FEM1B).
Fold change (FC) values expressed as a ratio between LO and CON groups, where FC >1.00 indicates an increase in gene expression and FC <−1.00 indicates a decrease in gene expression. 6 Fold change values expressed as a ratio between HI and CON groups, where FC >1.00 indicates an increase in gene expression and FC <−1.00 indicates a decrease in gene expression.
7
Fold change values expressed as a ratio between HI and LO groups, where FC >1.00 indicates an increase in gene expression and FC <−1.00 indicates a decrease in gene expression.
HI samples than CON, but no differences were found in the d 7 samples. This may indicate that PP2CB becomes activated after a longer exposure to AFB 1 .
YWHAZ
Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide interacts with tumor protein p53 to enhance the transcriptional activity of p53 and inhibit apoptosis. Binding of YWHAZ (or its family of genes or both) to BAD, Bax, and other apoptotic genes prevents further binding, inhibiting apoptosis (Xing et al., 2000; Tsuruta et al., 2004) . Expression of YWHAZ was greatest in HI barrows, intermediate in LO barrows, and least in CON barrows at d 70; the opposite expression pattern was observed at d 7, with CON barrows showing the greatest YWHAZ expression. This may suggest that YWHAZ response to AFB1 exposure is initially inhibited and is instead stimulated by a more chronic AFB 1 exposure to potentially decrease or regulate apoptotic activities.
BCL2/BNIP2
The B-cell lymphoma 2/adenovirus E1B 19kDa interacting protein 2 is pro-apoptotic. An interaction of BNIP2 with the prosurvival proteins BCL2 and E1B 19kDa decreases signaling and increases apoptosis (Zhang et al., 2003) . Expression of BNIP2 was greater in d 70 HI and LO than CON samples, but no differences were found in the d 7 samples, indicating chronic exposure to AFB 1 may be required for the pro-apoptotic function of BNIP2.
FEM1B
Fem-1 homolog B is pro-apoptotic and acts as a death receptor-associated protein to regulate apoptosis (Oyhenart et al., 2005) . In cancer cells, apoptosis is induced with increased FEM1B expression (Subauste et al., 2009 ). Greater expression of FEM1B was found in LO and HI compared with CON samples in d 70 samples only, suggesting a longer period of AFB 1 exposure (>7 d) may be required for FEM1B activation similar to BNIP2.
CUL2
Cullin 2 has been predicted to function as a tumor suppressor, but little research investigating the specific role of CUL2 has been conducted. Cullin 2 binds to form a complex that is a subunit on the RNA polymerase II transcriptional machinery, so CUL2 could potentially influence RNA expression (Maeda et al., 2008) . In d 70 samples, CUL2 was greater in LO and HI compared with CON samples, but no differences were found in d 7 samples. Expression of CUL2 may require a longer exposure period (>7 d) for activation.
IGF2
Insulin-like growth factor 2 is typically considered a growth promoter important for fetal development, but it has also been demonstrated that IGF2 is important for tumor formation (Sun et al., 2006) . Sakatani et al. (2005) reported that a loss of imprinting, or activation of the normally silent allele of IGF2, may predispose mammals to tumor development. Insulin-like growth factor 2 expression was less in HI and LO d 70 samples only, indicating IGF2 activity is more responsive to a chronic AFB 1 exposure.
NDUFS3
The NADH dehydrogenase (ubiquinone) Fe-S protein 3 is a subunit of the mitochondrial respiratory chain complex 1, which is necessary for the transfer of electrons from NADH to ubiquinone during the ATP production process (Huang et al., 2007) . Greater expression of NDUFS3 was found in LO and HI d 70 samples compared with CON samples, but no differences were observed at d 7, implying a role for NDUFS3 in the longer-term response to high dietary AFB 1 .
COL2A1
Collagen (type II, α 1), the gene responsible for coding type II collagen, has been used as a measure of apoptosis through caspase function (Nuttall et al., 2001) . Expression of COL2A1 was greater in LO and HI d 70 samples only, suggesting that this measure of apoptotic activity may not be suitable for shorter periods of AFB 1 administration.
AEN
Apoptosis enhancing nuclease encodes a DNase that enhances apoptosis by breaking DNA strands (Lee et al., 2005) . The p53 gene phosphorylation status regulates AEN expression, and AEN also regulates p53 expression (Kawase et al., 2008) . Expression of AEN was greater in LO and HI samples on d 70 and 7, suggesting this gene is important to both the short and long-term response to AFB 1 .
NAE1
Neural precursor cell-expressed developmentally downregulated 8 activating enzyme E1 subunit 1 is a regulatory subunit for the NEDD8 pathway, which regulates cullin activity and has a role in degradation of proteins important for cell-cycle progression, DNA damage, and stress response (Swords et al., 2010) . Overexpression of NAE1 leads to apoptosis due to NEDD8 conjugation deregulation (Soucy et al., 2009 ). Expression of NAE1 was greater in HI and LO than CON in d 70 samples only, suggesting that activation of the NEDD8 pathway may require a more chronic AFB 1 exposure.
Conclusions
These results demonstrate that hepatic genes are differentially expressed due to consumption of an AFB 1 -contaminated feed. In this study, genes associated with 43 unique functions were responsive to the AFB 1 administration. Of specific interest, 15 genes with apoptotic roles, CDKN1A, KNG1, ZMAT3, PIM1, STAT1, PP2CB, YWHAZ, BNIP2, FEM1B, CUL2, IGF2, NDUFS3, COL2A1 , AEN, and NAE1, were differentially expressed after long-term AFB 1 exposure (70 d). Of those 15 genes, 4 (CDKN1A, ZMAT3, YWHAZ, and AEN) were also differentially expressed after only a short-term exposure (7 d), indicating those genes may be early indicators of an apoptotic response to AFB 1 . Further study of these differentially expressed genes may lead to prevention strategies and treatments for aflatoxicosis. Additionally, early response genes may prove to be useful for early diagnosis of aflatoxicosis, or even indicate differences in tolerance to dietary AFB 1 .
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